LOGIQTM S8 XDclearTM 2.0
in Chronic Liver Disease Management
European recommendations and guidelines for
non-invasive test to assess liver disease
non-invasive test to assess liver disease
In Chronic Liver Disease management,
an early diagnosis and staging is extremely important to improve your patient's life conditions. You probably need a cost-effective, reproducible way to help identify high-risk patients, stage, track the disease progression quantifiably and make informed decisions to optimize treatment efficacy and cost.
New LOGIQ S8 XDclear 2.0, designed for your needs.
Leveraging the integration of the FibroScan® technology by Echosens, you can now benefit from the most comprehensive Liver package to improve the management of patients with chronic liver disease, with ease and confidence.
Ultrasound Imaging and Liver quantification together help you see more, and achieve more in clinical coverage, workflow and patient care.
Increased confidence with Ultrasound Imaging
High resolution B-Mode Imaging, advanced vascular performances and CEUS help get a better understanding of your patient’s conditions, including the most difficult cases.
Standardized measurements with FibroScan
Gold standard in Liver quantification, FibroScan with VCTE™ and CAP™ provides a Dual Quantification of both liver fibrosis and steatosis.
- Simple, quick learning
- Standardized and reproducible technique
- Clinical endorsement
- Exam’s Reimbursements1
- Established cutoff values for main liver etiologies
1 Reimbursement may vary depending on the country
See and Quantify with 2D-Shear Wave Elastography
Simple, accurate and reproducible, the LOGIQ S8’s 2D-SWE is very easy to learn and quick to use.
- Color coded elastogram with quantitative measurements
- Adjustable color box and ROI depth and size
- Measurements in kPa and m/s
- IQR/Median and STD/Mean
- Raw data capabilities – ability to measure from live or saved images/loops
Share on Twitter
Share on Facebook
Share on Google+
Share on LinkedIn